Decreased Expression of Hsa_circ_00001649 in Gastric Cancer and Its Clinical Significance

Table 2

Correlation between hsa_circ_0001649 expression and clinicopathological parameters in GC patients.

Parameters	Number of cases	Mean ± SD	value
Age
<60	42	0.14 ± 0.13
≥60	34	0.16 ± 0.12
Gender
Male	61	0.15 ± 0.12
Female	15	0.15 ± 0.16
Pathological differentiation
Well + moderate	31	0.18 ± 0.14
Poor + undifferentiation	45	0.12 ± 0.10
Depth of tumor invasion
Tis, T1a, T1b	8	0.15 ± 0.16
T2	10	0.08 ± 0.06
T3	10	0.16 ± 0.17
T4a, T4b	48	0.16 ± 0.17
Lymph node metastasis
N0	28	0.12 ± 0.11
N1	23	0.18 ± 0.13
N2	9	0.19 ± 01.8
N3a, N3b	16	0.14 ± 0.09
TNM Stage
I, II	39	0.14 ± 0.13
III, IV	37	0.16 ± 0.12
CEA
Positive	17	0.15 ± 0.11
Negative	59	0.15 ± 0.13
CA19-9
Positive	10	0.15 ± 0.12
Negative	66	0.15 ± 0.13
CA-724
Positive	8	0.08 ± 0.05
Negative	68	0.16 ± 0.13

chi-square for this statistic.